➡️ Check out our latest paper: - >60 y/o👴🏽pts with AML who had AlloSCT after Clad/LDAC/Ven alt with HMA-Ven (Clinical trial Tapan Kadia) had promsing survival outcomes✅️ - Superior RFS, lower CIR than >60 y/o pts👵🏻who had SCT after Int Rx MD Anderson Cancer Center acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

The best leukemia ladies group in the world - Lucia Masarova, MD MD Anderson Cancer Center Wei Ying Jen oncodaily.com/positive/80244… #Cancer #Hematology #Leukemia #OncoDaily #Oncology

Esta foto representa una sola cosa: Entrega total al imperialismo moderno (ONU) y negación del Nacionalismo mexicano (ausencia de bandera) Lo siento, hermanos mexicanos.

Yeah

Well-done to NCIS clinicians Prof Chng Wee Joo, Dr Wei Ying Jen and Dr Michelle Poon who were selected for presentations at the European Hematology Association Annual Congress #EHA2024!

CONGRESS | POSTER | #EHA2024 | Elias Jabbour MD Anderson Cancer Center reports follow-up for the phase III Golden Gate Study of blinatumomab alternating with low-intensity chemotherapy (LIC) in older adults with ND B-ALL. 13/14 (92.9%) patients had CR with blinatumomab & alternating LIC at

👉👉Delighted to present results of an investigator-initiated trial of Pirto + Ven + Obin as firstline Rx of pts with #CLL at European Hematology Association #EHA2024 A thread 🧵

NPM1-mutant myeloid neoplasms should be treated with AML-type treatment - Hagop Kantarjian,MD MD Anderson Cancer Center ACS Journal Cancer Georgina Gener Alex Bataller Guillermo Montalban-Bravo oncodaily.com/insight/89453.… #Cancer #AML #CancerResearch #Leusm #OncoDaily #Oncology

‼️New U.S. FDA approval of #BLINCYTO as consolidation for patients with acute lymphoblastic #leukemia 📢 If you are a #patient or #caregiver 👫 click 👉 on the link below to learn everything about this new approval ⤵️ #ALL #leusm #beatingcancer OncoAlert youtu.be/NSyCVk_Ii1o?si…

Detects chromosomal structural and copy number variations like karyotype+FISH+Array combined, with 10,000x better resolution than karyotype.

Another Jewel is coming!!! So thrilled!!! 🤩🤩🤩

For those trying to infantilize us Christians by saying our ''feelings were hurt'' by the opening of the olympics: This isn't about ''hurt feelings''. We're just sick and tired of the constant mockery of our Lord and our Religion. It's so cheap, so cowardice and so unoriginal.

Wow, this is crazy!

This is brilliant. Very difficult to explain something like this thoroughly and succinctly in less than three minutes. Charlie absolutely nails it.

#Delayedtweetalert Amazing lecture by Nitin Jain with a full insight into different options for frontline CLL. Is it better doublets or triple or monotherapy??? MD Anderson Cancer Center. Great updates will happen in next #ash2024 ASH #thrilled

Menin inhibitors could revolutionize leukemia treatment. This review demonstrates their potential impact on pediatrics and how collaboration with adults can accelerate their global availability for children. Ghayas Issa Hagop Kantarjian,MD nature.com/articles/s4137…

Great start in #soho2024 amazing talk in TP53m AML and MDS by Naval Daver, M.D. from MD Anderson Cancer Center. Big shout out to Jayastu Senapati from his contribution reflected in the data.

🙂 Happy to get the Second Place Poster Session Award at #SOHO2024 on ➡️ Venetoclax added to HyperCVAD-Nel-PegAsp In T-cell ALL/LBL: Phase 2 study MD Anderson Cancer Center Hagop Kantarjian,MD G Garcia-Manero

Day 1 at #SOHO24 great MDS session with data from former fellows Jayastu Senapati and Alex Bataller. Great biological NK cell activity in MDS by Dr Simona Colla. Cherry on the top of the cake with Dr Pui on ALL.

Day 1 at #SOHO24. ALL session with outstanding contribution from India, Mexico and Brasil!!! Big #shout to Roberta Demichelis for putting together the Mexican experience, a lot to learn from each other.